Business Wire | Dec 20, 2021 08:00AM EST

Seagen to Present at the J.P. Morgan Healthcare Conference

Dec. 20, 2021

BOTHELL, Wash.--(BUSINESS WIRE)--Dec. 20, 2021--Seagen Inc. (Nasdaq: SGEN) today announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from the investor section of Seagen's website at investor.seagen.com.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people's lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company's marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005153/en/

CONTACT: For Investors Peggy Pinkston Senior Vice President, Investor Relations (425) 527-4160 ppinkston@seagen.com For Media David Caouette Vice President, Corporate Communications (310) 430-3476 dcaouette@seagen.com